Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Dialyzer reprocessing with peracetic/acetic acid linked to higher mortality rate -- JAMA study.

This article was originally published in The Gray Sheet

Executive Summary

AUTOMATED DIALYZER REPROCESSING CAN REDUCE PATIENT MORTALITY associated with dialyzer reuse, Harold Feldman, MD, University of Pennsylvania Medical Center, Philadelphia et al. comment in the Aug. 28 issue of The Journal of the American Medical Association. Analyzing the effect of dialyzer reuse on patient outcomes, the authors found that in free-standing dialysis clinics, manual reprocessing resulted in a 7% increase in mortality compared to automatic reprocessing. Automated reprocessing was associated with a "small" reduction in mortality rates in freestanding dialysis clinics, Feldman et al. say.

Latest Headlines
See All
UsernamePublicRestriction

Register

MT006623

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel